Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Rothman

Showing results (291-300 of 532) with videos related to

Pageof 54
Sort By:
Synapse (New York, N.Y.)|April 15, 2000
Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implicationsM H Baumann, M A Ayestas, C M Dersch, et al.
Synapse (New York, N.Y.)|April 20, 2001
Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide and related compounds at the cloned human delta-opioid receptorH Xu, Y F Lu, J B Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2011
In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the ratMichael H Baumann, Robert D Clark, William L Woolverton, et al.
Neuropharmacology|September 1, 1990
Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptorsR B Rothman, J B Long, V Bykov, et al.
Journal of Molecular Biology|April 1, 2008
Insight into DNA and protein transport in double-stranded DNA viruses: the structure of bacteriophage N4Kyung H Choi, Jennifer McPartland, Irene Kaganman, et al.
The Journal of Clinical Investigation|August 30, 2005
Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of LangerhansAlexander S Banks, Jianze Li, Lisa McKeag, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 2005
Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptorHeng Xu, Xiaoying Wang, Darin Zimmerman, et al.
Neuropeptides|June 1, 1985
Evidence that the delta-selective alkylating agent, fit, alters the mu-noncompetitive opiate delta binding siteR B Rothman, J A Danks, M Herkenham, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1989
Apparent down-regulation of rat brain mu- and kappa-opioid binding sites labelled with [3H]cycloFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramineC Benkelfat, C S Aulakh, V Bykov, et al.
Neoplasia (New York, N.Y.)|July 13, 2012
A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesisXiaoxue Qiu, Guijie Guo, Ke Chen, et al.
Pageof 54

Showing results (291-300 of 532) with videos related to

Sort By:
Pageof 54
Synapse (New York, N.Y.)|April 15, 2000
Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implicationsM H Baumann, M A Ayestas, C M Dersch, et al.
Synapse (New York, N.Y.)|April 20, 2001
Opioid peptide receptor studies. 15. Relative efficacy of 4-[(N-allyl-3-methyl-4-piperidinyl)phenylamino]-N,N-diethylbenzamide and related compounds at the cloned human delta-opioid receptorH Xu, Y F Lu, J B Thomas, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2011
In vivo effects of amphetamine analogs reveal evidence for serotonergic inhibition of mesolimbic dopamine transmission in the ratMichael H Baumann, Robert D Clark, William L Woolverton, et al.
Neuropharmacology|September 1, 1990
Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptorsR B Rothman, J B Long, V Bykov, et al.
Journal of Molecular Biology|April 1, 2008
Insight into DNA and protein transport in double-stranded DNA viruses: the structure of bacteriophage N4Kyung H Choi, Jennifer McPartland, Irene Kaganman, et al.
The Journal of Clinical Investigation|August 30, 2005
Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of LangerhansAlexander S Banks, Jianze Li, Lisa McKeag, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 1, 2005
Chronic morphine up-regulates G alpha12 and cytoskeletal proteins in Chinese hamster ovary cells expressing the cloned mu opioid receptorHeng Xu, Xiaoying Wang, Darin Zimmerman, et al.
Neuropeptides|June 1, 1985
Evidence that the delta-selective alkylating agent, fit, alters the mu-noncompetitive opiate delta binding siteR B Rothman, J A Danks, M Herkenham, et al.
The Journal of Pharmacy and Pharmacology|December 1, 1989
Apparent down-regulation of rat brain mu- and kappa-opioid binding sites labelled with [3H]cycloFOXY following chronic administration of the potent 5-hydroxytryptamine reuptake blocker, clomipramineC Benkelfat, C S Aulakh, V Bykov, et al.
Neoplasia (New York, N.Y.)|July 13, 2012
A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesisXiaoxue Qiu, Guijie Guo, Ke Chen, et al.
Pageof 54